Xenetic Biosciences, Inc. financial data

Symbol
XBIO on Nasdaq
Location
945 Concord St., Framingham, MA
State of incorporation
NV
Fiscal year end
December 31
Former names
General Sales & Leasing, Inc. (to 1/10/2014), GENERAL AIRCRAFT INC. (to 2/12/2013)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 801 % -37.8%
Debt-to-equity 12.5 % +59.3%
Return On Equity -49.5 % -37.1%
Return On Assets -44 % -31.5%
Operating Margin -173 % +15.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.54M shares +0.09%
Common Stock, Shares, Outstanding 1.54M shares +0.62%
Entity Public Float 5.03M USD -55.6%
Common Stock, Value, Issued 1.55K USD +0.59%
Weighted Average Number of Shares Outstanding, Basic 1.54M shares +0.6%
Weighted Average Number of Shares Outstanding, Diluted 1.54M shares +0.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.52M USD +7.15%
Research and Development Expense 3.22M USD -13.2%
General and Administrative Expense 3.66M USD +5.67%
Operating Income (Loss) -4.36M USD +9.59%
Nonoperating Income (Expense) 284K USD -24.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -4.08M USD +8.29%
Earnings Per Share, Basic -2.66 USD/shares +33%
Earnings Per Share, Diluted -2.66 USD/shares +33%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 7.03M USD -37.6%
Property, Plant and Equipment, Net 0 USD
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 1.02M USD +44.6%
Assets 8.05M USD -32.7%
Accounts Payable, Current 243K USD -45.8%
Employee-related Liabilities, Current 217K USD -38.7%
Accrued Liabilities, Current 569K USD -27.6%
Liabilities, Current 1.01M USD -5.53%
Operating Lease, Liability, Noncurrent 0 USD
Liabilities 1.01M USD -5.53%
Accumulated Other Comprehensive Income (Loss), Net of Tax 254K USD 0%
Retained Earnings (Accumulated Deficit) -196M USD -2.12%
Stockholders' Equity Attributable to Parent 7.04M USD -35.4%
Liabilities and Equity 8.05M USD -32.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.16M USD -5.16%
Common Stock, Shares Authorized 10M shares 0%
Common Stock, Shares, Issued 1.54M shares +0.62%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.84M USD -30%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 40.6M USD +3.57%
Deferred Tax Assets, Gross 39.7M USD +2.95%
Property, Plant and Equipment, Gross 0 USD -100%
Operating Lease, Liability, Current 0 USD -100%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 208M USD +0.11%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 300K USD -40%